@prefix this: . @prefix rdfs: . @prefix xsd: . @prefix sio: . @prefix ncit: . @prefix lld: . @prefix miriam-gene: . @prefix miriam-pubmed: . @prefix eco: . @prefix wi: . @prefix prov: . @prefix pav: . @prefix prv: . @prefix dcterms: . @prefix np: . @prefix dgn-np: . @prefix dgn-gda: . @prefix dgn-void: . dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_head { this: np:hasAssertion dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_assertion; np:hasProvenance dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_provenance; np:hasPublicationInfo dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_publicationInfo; a np:Nanopublication . dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_assertion a np:Assertion . dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_provenance a np:Provenance . dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_publicationInfo a np:PublicationInfo . } dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_assertion { miriam-gene:596 a ncit:C16612 . lld:C0024299 a ncit:C7057 . dgn-gda:DGN13ed656928c930d62b8dc72e39b03083 sio:SIO_000628 miriam-gene:596, lld:C0024299; a sio:SIO_001121 . } dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_provenance { dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_assertion dcterms:description "[Previous studies have shown that the bcl-2 gene encodes a mitochondrial protein that contributes to neoplastic cell expansion primarily by promoting cell survival through interference with programmed cell death (PCD), also termed apoptosis. Because many chemotherapeutic drugs are capable of initiating pathways leading to apoptosis, we determined whether deregulated bcl-2 expression could render cells resistant to several drugs commonly used in the treatment of non-Hodgkin's lymphomas, including dexamethasone (DEX), methotrexate (MTX), 1-beta-D-arabinofuranosyl-cytosine (Ara-C), etoposide (VP-16), vincristine (VC), cisplatin (CP), and hydroperoxycyclophosphamide (4-HC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en; wi:evidence dgn-void:source_evidence_literature; sio:SIO_000772 miriam-pubmed:8417786; prov:wasDerivedFrom dgn-void:befree-2016; prov:wasGeneratedBy eco:ECO_0000203 . dgn-void:befree-2016 pav:importedOn "2016-02-19"^^xsd:date . dgn-void:source_evidence_literature a eco:ECO_0000212; rdfs:comment "Gene-disease associations inferred from text-mining the literature."@en; rdfs:label "DisGeNET evidence - LITERATURE"@en . } dgn-np:NP1341387.RA2PsROB3O-6uddZInyN4-mIDFWMEXHa9md8en7CVfIJU130_publicationInfo { this: dcterms:created "2016-05-13T12:51:54+02:00"^^xsd:dateTime; dcterms:rights ; dcterms:rightsHolder dgn-void:IBIGroup; dcterms:subject sio:SIO_000983; prv:usedData dgn-void:disgenetv3.0rdf; pav:authoredBy , , , , ; pav:createdBy ; pav:version "v4.0.0.0" . dgn-void:disgenetv3.0rdf pav:version "v4.0.0" . }